SRPT
Sarepta Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
No thesis.
Sarepta Therapeutics, Inc.
18.31
−0.31 · −1.66%
post 18.28 −0.17%
Fund move
Fund move
Linked news
News| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | BlackRockBlackRockindex-like | $341.3M | 16.83% | +28.73% | |
| 2 | State StreetState Streetindex-like | $160.2M | 7.90% | +34.82% | |
| 3 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $150.5M | 7.42% | +26.15% | |
| 4 | Two Sigma InvestmentsTwo Sigma | $82.6M | 4.08% | +0.12% | |
| 5 | Vanguard Capital ManagementVanguardindex-like | $82.5M | 4.07% | +0.30% | |
| 6 | First Trust AdvisorsFirst Trust | $78.5M | 3.87% | +5.57% | |
| 7 | AQR Capital ManagementAQR | $76.9M | 3.79% | −32.76% | |
| 8 | Geode Capital ManagementGeodeindex-like | $49.8M | 2.46% | +39.37% | |
| 9 | Erste Asset ManagementErste | $45.5M | 2.24% | −13.47% | |
| 10 | Marshall WaceMarshall Wace | $39.6M | 1.96% | +204.25% | |
| 11 | Morgan StanleyMorgan Stanley | $39.6M | 1.95% | −15.18% | |
| 12 | Standard Life AberdeenStandard Life Aberdeen | $39.4M | 1.95% | −5.34% | |
| 13 | Bank of AmericaBank of America | $36.9M | 1.82% | −4.19% | |
| 14 | Goldman Sachs GroupGoldman Sachs | $36.7M | 1.81% | +89.43% | |
| 15 | Susquehanna International GroupSusquehanna International | $34.6M | 1.71% | −49.52% | |
| 16 | UBS GroupUBS | $29.2M | 1.44% | −27.24% | |
| 17 | Federated InvestorsFederated Investors | $28.6M | 1.41% | −10.96% | |
| 18 | Citadel AdvisorsCitadel | $27.7M | 1.37% | −32.32% | |
| 19 | LMR PartnersLMR Partners | $25.0M | 1.23% | −12.52% | |
| 20 | Northern TrustNorthern Trustindex-like | $21.8M | 1.07% | +67.17% | |
| 21 | Millennium ManagementMillennium | $21.4M | 1.06% | −2.31% | |
| 22 | T. Rowe Price Investment ManagementT. Rowe Price | $20.8M | 1.02% | +2.01% | |
| 23 | CitigroupCitigroup | $20.8M | 1.02% | +0.64% | |
| 24 | Renaissance TechnologiesRenaissance Technologies | $20.2M | 0.99% | −32.65% | |
| 25 | Charles Schwab Investment ManagementCharles Schwabindex-like | $17.6M | 0.87% | +23.91% |
327 managers report $2.0B of Sarepta Therapeutics on form 13F for the quarter ended Jun 30 '26. 32 of them hold 80% of it; BlackRock is largest at 16.83%.
Expected move
Inputsspot 18.62exp Nov 6ATM strike 18.5ATM straddle 2.15IV 105%